The effect of β-G prodrug on β-glucuronidiase-cDNA transfect ed bile duct carcinoma cell line QBC939

戴辉,窦科峰,李开宗,陈勇,岳树强,侯小娟,仇凯,陈志南
DOI: https://doi.org/10.3969/j.issn.1009-3079.2001.10.028
2001-01-01
Abstract:Objective To investigate the growth inhib itory effect of β-G gene and β-G prodrug on human bile duct carcinoma cell l ine (QBC939). Methods Retroviral vector was used to tran sfect the pDOR-βG gene into the bile duct carcinoma cell line (QBC939) by cati on lipofectin. The expression of pDOR-βG gene was detected by immunohistochemi stry and the transfected cells were also observed. The expression of pDOR-βG g ene and effect of β-G prodrug on transfected cells growth were studied. Results The positive cell clone selected by G418 system w as proved to be a bile duct carcinoma model with high expression of βG. The expression of pDOR-βG in the transfected cells was first verified by immunohistochemistry, immunoflurescence and in situ hybridization. It was found that β-G prodrug had a significantly inhibitory effect on pDOR-βG-QBC939 cell lines by using MTT method. When the β-G prodrug concentration was 0.292 g/L, inhibitory rate of p DOR-βG-QBC939 cell lines was 67.6%. Conclusion β-G gene/β-G prodrug system was a new suic ide gene system, which may provide a novel gene therapeutic strategy for bile du ct carcinoma.
What problem does this paper attempt to address?